药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Methylphenobarbital
Abetimus
The risk or severity of adverse effects can be increased when Docetaxel is combined with Abetimus.
Methylphenobarbital
Mepolizumab
The risk or severity of adverse effects can be increased when Docetaxel is combined with Mepolizumab.
Methylphenobarbital
Human interferon omega-1
The risk or severity of adverse effects can be increased when Docetaxel is combined with Human interferon omega-1.
Methylphenobarbital
Briakinumab
The risk or severity of adverse effects can be increased when Docetaxel is combined with Briakinumab.
Methylphenobarbital
Gallium nitrate
The risk or severity of adverse effects can be increased when Docetaxel is combined with Gallium nitrate.
Methylphenobarbital
Glatiramer
The risk or severity of adverse effects can be increased when Docetaxel is combined with Glatiramer.
Methylphenobarbital
Interferon alfa
The risk or severity of adverse effects can be increased when Docetaxel is combined with Interferon alfa.
Methylphenobarbital
Pirfenidone
The risk or severity of adverse effects can be increased when Docetaxel is combined with Pirfenidone.
Methylphenobarbital
Aldosterone
The risk or severity of adverse effects can be increased when Docetaxel is combined with Aldosterone.
Methylphenobarbital
Brequinar
The risk or severity of adverse effects can be increased when Docetaxel is combined with Brequinar.
Methylphenobarbital
2-Methoxyethanol
The risk or severity of adverse effects can be increased when Docetaxel is combined with 2-Methoxyethanol.
Methylphenobarbital
Vorinostat
The risk or severity of adverse effects can be increased when Docetaxel is combined with Vorinostat.
Methylphenobarbital
Castanospermine
The risk or severity of adverse effects can be increased when Docetaxel is combined with Castanospermine.
Methylphenobarbital
Hydroxychloroquine
The risk or severity of adverse effects can be increased when Docetaxel is combined with Hydroxychloroquine.
Methylphenobarbital
Stepronin
The risk or severity of adverse effects can be increased when Docetaxel is combined with Stepronin.
Methylphenobarbital
Ciclesonide
The risk or severity of adverse effects can be increased when Docetaxel is combined with Ciclesonide.
Methylphenobarbital
Nelarabine
The risk or severity of adverse effects can be increased when Docetaxel is combined with Nelarabine.
Methylphenobarbital
Decitabine
The risk or severity of adverse effects can be increased when Docetaxel is combined with Decitabine.
Methylphenobarbital
Eculizumab
The risk or severity of adverse effects can be increased when Docetaxel is combined with Eculizumab.
Methylphenobarbital
Lomustine
The risk or severity of adverse effects can be increased when Lomustine is combined with Docetaxel.